India’s fast-growing nutraceutical industry is entering a critical transition phase, with regulators and industry leaders warning that weak scientific validation, influencer-driven misinformation and digital compliance gaps could undermine consumer trust just as the market prepares for large-scale expansion.At the 5th Annual Nutrify C-Suite Sumflex 2026 summit in Mumbai, speakers said India’s preventive healthcare opportunity could grow sharply over the next decade — but only if the sector strengthens transparency, evidence-backed claims and regulatory accountability.India’s nutraceutical market, estimated at roughly $1 billion at the direct consumer level but significantly larger when functional foods, fortified products and exports are included, is expanding at double-digit rates amid rising health consciousness, preventive healthcare spending and rapid growth in online supplement consumption.Industry estimates cited by experts place the broader Indian nutraceutical manufacturing ecosystem between $8.9 billion and $38.7 billion, reflecting the fragmented nature of the category and differences in how functional foods and botanical exports are classified.Yet penetration remains among the lowest globally. While Japan consumes nearly 350 nutraceutical products per person annually, India consumes fewer than two, according to speakers at the summit. That gap, industry participants argued, increasingly reflects a credibility challenge rather than merely an affordability issue.“Consumer trust cannot be negotiated. It is beyond regulatory compliance,” said Vaibhav Kulkarni, founder of Zantus Life Sciences and moderator of the panel discussion, as speakers repeatedly returned to concerns around misleading influencer marketing, weak scientific substantiation, poor-quality disclosures and inconsistent claims across digital platforms.transition phaseThe discussion highlighted how India’s nutraceutical industry is entering a transition phase where quality, transparency and evidence-backed claims could increasingly determine long-term market leadership.Industry experts tracking the sector said FY26 marks a shift from post-pandemic product proliferation toward institutional consolidation, with legacy consumer companies increasingly treating nutraceuticals as a core preventive-healthcare category rather than a niche online trend.The industry is estimated to have expanded 10.5 per cent –13 per cent year-on-year into FY26, driven by D2C maturity, preventive-health demand and rising strategic investments by larger consumer groups.One of the clearest signs of that transition came earlier this year when Hindustan Unilever acquired the remaining 49 per cent stake in OZiva for ₹824 crore, turning the digital-first wellness brand into a wholly owned subsidiary and signalling rising institutional confidence in India’s nutrition and preventive-health market.Kulkarni said dedicated nutraceutical regulations introduced under FSSAI roughly six years ago helped give the industry a clearer identity after years of overlap between food products, Ayurveda-linked wellness formulations and pharmaceuticals.“The nutraceutical regulation gave the industry its identity,” he said, adding that the operationalisation of the framework in 2022 and 2023 helped formalise a category that had long existed in a regulatory grey area.Industry executives said nutraceuticals continue to occupy a hybrid space between food and pharmaceuticals, creating persistent challenges around claims, compliance and consumer expectations.The Influencer Loophole“There has to be absolute transparency about the ingredients,” said Anupama Patil, Assistant Commissioner at Maharashtra FDA. “Whatever you are claiming, it has to be backed by evidence.”A major concern during the summit was the widening disconnect between regulated product labels and largely unregulated digital marketing ecosystems.Patil warned that influencer-led promotion of nutraceutical products has created a grey zone where claims that may not be legally permissible on packaging are routinely amplified online.“These are not people who come from a regulatory background. They are not aware of what they are saying,” Patil said, referring to influencers and content creators promoting rapid weight loss, complexion changes and disease-management claims without scientific backing.The discussion repeatedly highlighted what industry participants described as a modern regulatory mismatch: while nutraceutical packaging and labels are governed by formal food-safety standards, a growing share of consumer discovery is now driven by influencers, short-video platforms and e-commerce marketplaces operating in a far less structured environment.Patil said online platforms selling nutraceutical products have a responsibility to display labels and disclosures clearly so consumers understand exactly what they are purchasing.“With the huge e-commerce boom we are seeing, if e-commerce platforms display label panels clearly in HD, it will be very effective for both regulators and consumers,” she said. “It builds trust in the brand and in the regulatory system.”Food, Pharma and the Science GapThe summit also repeatedly framed nutraceuticals as part of India’s larger preventive healthcare transition, “If we want to reduce the healthcare burden in India, nutraceuticals are a good approach because they represent preventive healthcare. Pharmaceuticals are about sick care,” Kulkarni said.Industry researchers estimate the Indian nutraceutical market could more than double over the next decade, reaching anywhere between $23 billion and $85 billion by 2033–34 if current growth trajectories sustain. Analysts attribute the runway to rising lifestyle diseases, growing health awareness, urban wellness consumption and India’s advantage in plant-based ingredients such as ashwagandha, turmeric and moringa.Medical experts at the summit stressed that claims around diabetic-friendly foods, immunity support and functional nutrition must be backed by laboratory studies, glycaemic index validation or clinically accepted evidence frameworks rather than marketing language alone.“Whenever you are making a claim, that claim has to be backed,” said Nandan Joshi, Head of Medical Affairs at Dr Reddy’s–Nestlé Health Sciences. He cited glycaemic index testing as an example of the type of scientific validation required for diabetic-management claims.Published on June 4, 2026